"{\n \"business_address\": \"9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA 92123\", \n \"business_phone_no\": \"8587462400\", \n \"ceo\": \"Mick Farrell\", \n \"cik\": \"0000943819\", \n \"company_url\": \"www.resmed.com\", \n \"employees\": 5250, \n \"entity_legal_form\": null, \n \"entity_status\": null, \n \"hq_address1\": null, \n \"hq_address2\": null, \n \"hq_address_city\": null, \n \"hq_address_postal_code\": null, \n \"hq_country\": \"United States of America\", \n \"hq_state\": \"California\", \n \"inc_country\": \"United States of America\", \n \"inc_state\": \"Delaware\", \n \"industry_category\": \"Health Services\", \n \"industry_group\": \"Medical Appliances & Equipment\", \n \"latest_filing_date\": \"2017-08-04\", \n \"legal_name\": \"RESMED INC\", \n \"lei\": null, \n \"long_description\": \"ResMed Inc. designs, develops, manufactures, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders. Its portfolio of products include devices, such as air flow generators, ventilators, and oxygen concentrators; diagnostic products; mask systems; headgear and other accessories; dental devices; portable oxygen concentrators; and cloud-based software informatics solutions. The company also produces continuous positive airway pressure, variable positive airway pressure, and AutoSet systems for the titration and treatment of sleep disordered breathing (SDB). In addition, it offers data communications and control products, such as EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 100 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.\", \n \"mailing_address\": \"9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA 92123\", \n \"name\": \"ResMed Inc\", \n \"sector\": \"Healthcare\", \n \"securities\": [\n  {\n   \"composite_figi\": \"BBG000L4M7F1\", \n   \"composite_figi_ticker\": \"RMD:US\", \n   \"currency\": \"USD\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XNYS\", \n   \"figi\": \"BBG000L4M7F1\", \n   \"figi_exch_cntry\": \"US\", \n   \"figi_ticker\": \"RMD:US\", \n   \"figi_uniqueid\": \"EQ0017102300001000\", \n   \"last_crsp_adj_date\": \"2017-08-15\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XNYS\", \n   \"primary_listing\": true, \n   \"security_name\": \"RESMED INC\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001SBGRC2\", \n   \"stock_exchange\": \"NYSE\", \n   \"ticker\": \"RMD\"\n  }, \n  {\n   \"composite_figi\": \"BBG000L4M7F1\", \n   \"composite_figi_ticker\": \"RMD:US\", \n   \"currency\": \"USD\", \n   \"delisted_security\": true, \n   \"etf\": false, \n   \"exch_symbol\": \"^OTCB\", \n   \"figi\": \"BBG000L4M7F1\", \n   \"figi_exch_cntry\": \"US\", \n   \"figi_ticker\": \"RMD:US\", \n   \"figi_uniqueid\": \"EQ0017102300001000\", \n   \"last_crsp_adj_date\": null, \n   \"market_sector\": \"Equity\", \n   \"mic\": \"OTCB\", \n   \"primary_listing\": false, \n   \"security_name\": \"RESMED INC.\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001SBGRC2\", \n   \"stock_exchange\": \"OTCM\", \n   \"ticker\": \"RSMDF\"\n  }, \n  {\n   \"composite_figi\": \"BBG000JN7402\", \n   \"composite_figi_ticker\": \"RME:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XSTU\", \n   \"figi\": \"BBG000JN7661\", \n   \"figi_exch_cntry\": \"GS\", \n   \"figi_ticker\": \"RME:GS\", \n   \"figi_uniqueid\": \"EQ0017102300001001\", \n   \"last_crsp_adj_date\": \"2017-08-15\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XSTU\", \n   \"primary_listing\": false, \n   \"security_name\": \"RESMED INC.\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001SBGRC2\", \n   \"stock_exchange\": \"STU\", \n   \"ticker\": \"RME\"\n  }, \n  {\n   \"composite_figi\": \"BBG000JN7402\", \n   \"composite_figi_ticker\": \"RME:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XMUN\", \n   \"figi\": \"BBG000JN76B5\", \n   \"figi_exch_cntry\": \"GM\", \n   \"figi_ticker\": \"RME:GM\", \n   \"figi_uniqueid\": \"EQ0017102300001001\", \n   \"last_crsp_adj_date\": \"2017-08-15\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XMUN\", \n   \"primary_listing\": false, \n   \"security_name\": \"RESMED INC.\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001SBGRC2\", \n   \"stock_exchange\": \"MUN\", \n   \"ticker\": \"RME\"\n  }, \n  {\n   \"composite_figi\": \"BBG000JN7402\", \n   \"composite_figi_ticker\": \"RME:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": true, \n   \"etf\": false, \n   \"exch_symbol\": \"^XETR\", \n   \"figi\": \"BBG000JN7402\", \n   \"figi_exch_cntry\": \"GR\", \n   \"figi_ticker\": \"RME:GR\", \n   \"figi_uniqueid\": \"EQ0017102300001001\", \n   \"last_crsp_adj_date\": null, \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XETR\", \n   \"primary_listing\": false, \n   \"security_name\": \"RESMED INC.\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001SBGRC2\", \n   \"stock_exchange\": \"XETRA\", \n   \"ticker\": \"RME\"\n  }, \n  {\n   \"composite_figi\": \"BBG000JN7402\", \n   \"composite_figi_ticker\": \"RME:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XFRA\", \n   \"figi\": \"BBG000JN74G5\", \n   \"figi_exch_cntry\": \"GF\", \n   \"figi_ticker\": \"RME:GF\", \n   \"figi_uniqueid\": \"EQ0017102300001001\", \n   \"last_crsp_adj_date\": \"2017-08-15\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XFRA\", \n   \"primary_listing\": false, \n   \"security_name\": \"RESMED INC\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001SBGRC2\", \n   \"stock_exchange\": \"FRA\", \n   \"ticker\": \"RME\"\n  }, \n  {\n   \"composite_figi\": \"BBG000JN7402\", \n   \"composite_figi_ticker\": \"RME:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XBER\", \n   \"figi\": \"BBG000JN77K3\", \n   \"figi_exch_cntry\": \"GB\", \n   \"figi_ticker\": \"RME:GB\", \n   \"figi_uniqueid\": \"EQ0017102300001001\", \n   \"last_crsp_adj_date\": \"2017-08-15\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XBER\", \n   \"primary_listing\": false, \n   \"security_name\": \"RESMED INC.\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001SBGRC2\", \n   \"stock_exchange\": \"BER\", \n   \"ticker\": \"RME\"\n  }\n ], \n \"short_description\": \"ResMed, Inc. engages in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders including sleep disordered breathing, chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its product portfolio includes obstructive sleep apnea, and other respiratory disorders that occur during sleep. The company was founded by Peter C. Farrell in June 1989 and is headquartered in San Diego, CA.\", \n \"sic\": 3841, \n \"standardized_active\": true, \n \"stock_exchange\": \"NYSE\", \n \"template\": \"industrial\", \n \"ticker\": \"RMD\"\n}"